NeuroBo Pharmaceuticals
Stock Forecast, Prediction & Price Target
NeuroBo Pharmaceuticals Financial Estimates
NeuroBo Pharmaceuticals Revenue Estimates
NeuroBo Pharmaceuticals EBITDA Estimates
NeuroBo Pharmaceuticals Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | ||
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $7K Low: $7K High: $7K avg. 0% | Avg: $7K Low: $7K High: $7K avg. 0% | ||
Net Income
% change YoY
| $-15.22M N/A | $-6.11M 59.82% | $-12.47M -103.92% | Avg: $-30.03M Low: $-14.04M High: $-9.93M avg. -140.83% | Avg: $-34.44M Low: $-12.98M High: $-7.75M avg. -14.68% | ||
EBITDA
% change YoY
| $-15.29M N/A | $-11.50M 24.82% | $-15.88M -38.07% | Avg: $4.2K Low: $4.2K High: $4.2K avg. 100.02% | Avg: $4.2K Low: $4.2K High: $4.2K avg. 0% | ||
EPS
% change YoY
| -$157.85 N/A | -$19.01 87.95% | -$2.46 87.05% | Avg: -$2.44 Low: -$2.77 High: -$1.96 avg. 0.81% | Avg: -$2.08 Low: -$2.56 High: -$1.53 avg. 14.61% | ||
Operating Expenses
% change YoY
| $15.29M N/A | $11.41M -25.36% | $15.88M 39.13% | Avg: $1.35M Low: $1.35M High: $1.35M avg. -91.49% | Avg: $1.35M Low: $1.35M High: $1.35M avg. 0% | ||
FAQ
What is NeuroBo Pharmaceuticals stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -77.76% in 2025-2026.
We have gathered data from 2 analysts. Their low estimate is -14.04M, average is -30.03M and high is -9.93M.
What is NeuroBo Pharmaceuticals stock revenue growth forecast?
We have gathered data from 3 analysts. Their low revenue estimate is $7K, average is $7K and high is $7K.
What is NeuroBo Pharmaceuticals stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 7.71% in 2025-2026.
We have gathered data from 2 analysts. Their low earnings per share estimate is -$2.77, average is -$2.44 and high is $-1.96.